Thromb Haemost 1967; 05(03/04): 433-438
DOI: 10.1055/s-0038-1655052
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Fibrinolytic System in Hypotensive Patients; with a Special Reference to the Effect of Epsilon-Amino Caproic Acid (EACA)

Authors

  • A Gabryelewicz

    1   Department of Physiological Chemistry (Head: Doc. S. Niewiarowslci, M. D) and Second Department of Medicine (Head: Prof. J. Chlebowski, M. D), Medical School, Białystok ( Poland)
  • S Niewiarowski

    1   Department of Physiological Chemistry (Head: Doc. S. Niewiarowslci, M. D) and Second Department of Medicine (Head: Prof. J. Chlebowski, M. D), Medical School, Białystok ( Poland)
  • J Prokopowicz

    1   Department of Physiological Chemistry (Head: Doc. S. Niewiarowslci, M. D) and Second Department of Medicine (Head: Prof. J. Chlebowski, M. D), Medical School, Białystok ( Poland)
  • K Worowski

    1   Department of Physiological Chemistry (Head: Doc. S. Niewiarowslci, M. D) and Second Department of Medicine (Head: Prof. J. Chlebowski, M. D), Medical School, Białystok ( Poland)
Further Information

Publication History

Publication Date:
26 June 2018 (online)

Preview

Summary

An acceleration of euglobulin fibrinolysis and a slight decrease of plasminogen and of antiplasmin were found in idiopathic hypotensive patients. EACA administered orally in daily doses 0.1 g /kg of weight for 4 days produced both an inhibition of fibrinolysis and a significant rise in arterial blood pressure in 15 of 18 patients studied. It has been suggested that the pressure effect of EACA may be mediated by inhibiting plasminogen activation.